When to take insulin with a hybrid closed-loop pump
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial compares taking your rapid insulin at mealtime versus after a meal when using the Medtronic 780G pump. It aims to see which timing helps better manage blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 diabetes.
- You have been using the Medtronic 780G pump with Ultra Rapid Lispro (a fast insulin) for at least 2 months.
- You are willing to follow the study schedule and answer questions remotely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
This trial tests whether a special exercise setting (SmartGuard) on the MiniMed 780G insulin pump helps manage blood sugar during physical activity better than the standard setting (Temp Target). If you have type 1 diabetes and regularly exercise, this study could help find the best way to use your pump during workouts.
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.